Skip to main content
Clinical Trials/NCT01243918
NCT01243918
Terminated
Not Applicable

Evaluation of Oxygen Therapy Delivery Systems in Hypoxemic Acute Respiratory Failure

Nantes University Hospital1 site in 1 country16 target enrollmentNovember 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Respiratory Failure
Sponsor
Nantes University Hospital
Enrollment
16
Locations
1
Primary Endpoint
Calcul of the ratio PaO2/FiO2
Status
Terminated
Last Updated
12 years ago

Overview

Brief Summary

The main objective of this study is to evaluate the efficiency of the oxygen therapy delivery system Optiflow® compared to 2 others standard oxygen therapy delivery systems (Ospal®, non invasive ventilation).12 immunocompetent patients will compare the successive use of oxygen therapy delivery systems Optiflow®/Ospal® and 12 immunodeficient patients will compare the successive use of systems Optiflow®/Non invasive ventilation.

Registry
clinicaltrials.gov
Start Date
November 2010
End Date
June 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient hospitalized in the intensive care unit of Nantes University Hospital
  • Signed informed consent
  • Patient with not hypercapnic acute hypoxemic respiratory failure
  • Immunocompetent and immunodeficient patient

Exclusion Criteria

  • Age \< 18 years
  • Pregnancy
  • Contra-indication to non invasive ventilation
  • Allergy to xylocaine
  • Coagulation troubles
  • Tracheotomized patient
  • Urgent indication to intubation
  • Hypercapnic acute respiratory failure
  • Acute pulmonary edema
  • Face or nose malformation

Outcomes

Primary Outcomes

Calcul of the ratio PaO2/FiO2

Time Frame: one hour after each system used

The main objective of this study is to evaluate the efficiency of the oxygen therapy delivery system Optiflow® compared to 2 others standard oxygen therapy delivery systems (Ospal®, non invasive ventilation) by calculating the ratio PaO2/FiO2

Secondary Outcomes

  • number of participants with adverse events
  • measure of respiratory frequency and blood gas
  • measure of positive and expiratory pressure

Study Sites (1)

Loading locations...

Similar Trials